Internal Medicine

3151 questions

Question 1541Question →

A 24-year-old man with type 1 diabetes mellitus is brought to the emergency department due to altered mental status, generalized weakness, and abdominal pain for the past 24 hours. He recently had an upper respiratory infection and stopped taking his insulin due to poor oral intake. His blood pressure is 90/60 mm Hg, heart rate is 118/min, and respiratory rate is 24/min with deep, rapid breaths. Laboratory results show a blood glucose of 580 mg/dL, arterial pH of 7.12, serum bicarbonate of 10 mEq/L, and strongly positive serum ketones. Arrange the following management steps in the most appropriate chronological order for the optimal acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for DKA management is: 1) Administer IV normal saline, 2) Check potassium levels, 3) Start IV regular insulin, 4) Add dextrose to IV fluids when glucose reaches 200 mg/dL, and 5) Transition to subcutaneous insulin when the anion gap closes.
The acute management of diabetic ketoacidosis (DKA) must follow a strict, protocolized sequence to resolve the metabolic derangements safely. The most immediate life threat is hypovolemia from massive osmotic diuresis, making aggressive fluid resuscitation with normal saline the paramount first step. The second most critical step is evaluating serum potassium. Because patients have a total-body potassium deficit (despite potentially normal or high initial serum levels due to acidosis-induced extracellular shifts), insulin must NOT be given if serum potassium is < 3.3 mEq/L, as insulin will rapidly drive potassium into cells and cause lethal arrhythmias. Once safe potassium levels are confirmed, an intravenous insulin infusion is started to halt lipolysis and clear ketones. As treatment progresses, blood glucose typically falls faster than ketones are cleared. Therefore, when glucose reaches 200 mg/dL, 5% dextrose must be added to the IV fluids to prevent hypoglycemia while the insulin infusion is continued to close the anion gap. Finally, once the anion gap normalizes and the patient can eat, they are transitioned to subcutaneous insulin.

Step-by-Step Solution

1
Restore intravascular volume.
Administer 0.9% normal saline bolus.
Patients with DKA have profound total-body water deficits due to osmotic diuresis; correcting volume depletion improves tissue perfusion and renal clearance of glucose.
2
Prevent severe hypokalemia.
Check potassium levels before initiating insulin.
Insulin therapy drives potassium into cells. If a patient is already hypokalemic (potassium < 3.3 mEq/L), insulin administration can precipitate life-threatening cardiac arrhythmias.
3
Halt ketogenesis and correct acidosis.
Begin continuous IV insulin infusion.
Insulin directly suppresses lipolysis and ketone production, which treats the underlying pathophysiology and begins to close the anion gap.
4
Prevent treatment-induced hypoglycemia.
Add 5% dextrose to IV fluids when blood glucose reaches 200 mg/dL.
Because acidosis takes longer to clear than hyperglycemia, insulin must be continued even after glucose normalizes. Adding dextrose allows insulin continuation without causing hypoglycemia.
5
Transition to maintenance therapy.
Initiate subcutaneous insulin.
Once the anion gap has closed, acidosis is resolved, and the patient is awake and able to eat, they can be safely transitioned to a subcutaneous insulin regimen with a brief overlap.

Key Concept

Sequential acute management of Diabetic Ketoacidosis (DKA)
Estimated Time:1m 30s
Question 1542Question →

A 7474-year-old man is evaluated on postoperative day 33 following an uncomplicated laparoscopic cholecystectomy. Over the past 1212 hours, he has developed a fever and severe pain in his right knee. He states the pain is so intense that he cannot bear weight or tolerate the bedsheets touching his leg. His medical history is significant for essential hypertension, diet-controlled type 2 diabetes mellitus, and hypothyroidism. Current medications include lisinopril and levothyroxine. His temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure is 138/86 mmHg138/86\text{ mmHg}, and pulse is 98/min98/\text{min}. Cardiopulmonary examination is unremarkable. His abdomen is soft and non-tender, and the surgical incisions are clean and intact. Examination of the right knee reveals marked erythema, warmth, and a large effusion. The joint is exquisitely tender to palpation and passive range of motion. Laboratory studies show a leukocyte count of 13,500/mm313,500/\text{mm}^3 and a thyroid-stimulating hormone (TSH) level of 5.5 mIU/L5.5\text{ mIU/L}. Arthrocentesis of the right knee yields 3 mL3\text{ mL} of cloudy synovial fluid. Analysis of the fluid reveals a leukocyte count of 28,000/mm328,000/\text{mm}^3 with 80%80\% neutrophils. Polarized light microscopy demonstrates rhomboid-shaped crystals with weak positive birefringence. Gram stain of the synovial fluid reveals no organisms. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intra-articular triamcinolone injection

Answer

The correct answer is intra-articular triamcinolone injection.
The correct answer is an intra-articular triamcinolone injection. This patient is experiencing an acute flare of calcium pyrophosphate dihydrate (CPPD) crystal arthritis, commonly referred to as pseudogout. Acute crystal arthropathies are frequently triggered by the physiological stress of surgery or severe medical illness. The diagnosis is confirmed by the synovial fluid analysis revealing rhomboid-shaped, weakly positively birefringent crystals. The synovial white blood cell count is highly inflammatory (28,000/mm328,000/\text{mm}^3) and can sometimes overlap with the septic range, but the identification of crystals and a negative Gram stain point to CPPD as the primary etiology. The fever is a systemic manifestation of the intense autoinflammatory response induced by the crystals. For a localized, monoarticular flare in an elderly postoperative patient, an intra-articular glucocorticoid injection is the most appropriate first-line therapy. It provides rapid relief while avoiding the systemic adverse effects associated with NSAIDs (e.g., acute kidney injury, gastrointestinal bleeding) and colchicine, which are less ideal in the immediate postoperative period.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and setting.
An elderly patient on postoperative day 3 presents with an acute, severe monoarticular arthritis (hot, swollen, tender right knee) accompanied by a fever.
Postoperative status is a major physiological stressor that frequently triggers acute flares of crystal arthropathies.
2
Interpret the synovial fluid analysis.
The fluid shows 28,000 WBCs/mm328,000\text{ WBCs/mm}^3 (inflammatory range), a negative Gram stain, and rhomboid-shaped crystals with weak positive birefringence.
These findings are strictly diagnostic for calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, commonly known as pseudogout.
3
Determine the optimal acute management for monoarticular pseudogout in this specific patient.
Intra-articular glucocorticoid injection is selected.
In an elderly patient recovering from surgery, systemic therapies like NSAIDs (risk of AKI, bleeding) and colchicine (gastrointestinal toxicity, dosing adjustments) carry significant risks. An intra-articular injection provides rapid, localized relief with minimal systemic side effects.

Key Concept

Diagnosis and management of acute calcium pyrophosphate dihydrate (CPPD) crystal arthritis (pseudogout) in the postoperative setting.
Question 1543Question →

A 22-year-old man with type 1 diabetes mellitus is brought to the emergency department with abdominal pain, vomiting, and deep, rapid breathing. Laboratory studies confirm severe diabetic ketoacidosis (DKA) with a blood glucose of 540 mg/dL and a serum potassium of 4.8 mEq/L. Arrange the following management steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of DKA management is: 1) IV normal saline bolus, 2) IV regular insulin infusion, 3) Addition of 5% dextrose to IV fluids, and 4) Transition to subcutaneous insulin.
The standard sequence for DKA management begins with aggressive volume expansion using 0.9% normal saline to correct severe dehydration caused by osmotic diuresis. After confirming that serum potassium is >3.3 mEq/L, a continuous IV regular insulin infusion is started to halt lipolysis and ketogenesis. As the blood glucose level falls to around 200-250 mg/dL, 5% dextrose is added to the maintenance IV fluids; this prevents hypoglycemia while allowing the insulin infusion to continue until the anion gap closes. Finally, once the anion gap has normalized, acidosis has resolved, and the patient can tolerate oral intake, the patient is transitioned to subcutaneous insulin, and the IV insulin is discontinued shortly thereafter.

Step-by-Step Solution

1
Administer an initial rapid intravenous bolus of 0.9% normal saline
Restores intravascular volume and renal perfusion
Patients with DKA are profoundly dehydrated due to osmotic diuresis; volume expansion is the most critical initial intervention.
2
Initiate a continuous intravenous regular insulin infusion
Lowers serum glucose and stops ketone production
Since the serum potassium is safely above 3.3 mEq/L, insulin can be safely administered to address the underlying insulin deficiency without causing severe hypokalemia.
3
Add 5% dextrose to the intravenous fluids
Maintains blood glucose levels while allowing continued insulin administration
Insulin must be continued until the anion gap closes. Adding dextrose prevents hypoglycemia when blood glucose reaches ~200 mg/dL.
4
Transition to a subcutaneous basal-bolus insulin regimen
Allows safe discontinuation of the IV insulin drip
Once ketoacidosis is resolved (closed anion gap) and the patient can eat, IV insulin can be transitioned to a long-term subcutaneous regimen.

Key Concept

The chronological management of diabetic ketoacidosis prioritizes fluid resuscitation, followed by insulin therapy, dextrose supplementation when glucose falls, and transition to subcutaneous insulin upon resolution.
Question 1544Question →

A 61-year-old man is evaluated in the intensive care unit to optimize his medication regimen. He was admitted a week ago after sustaining multiple severe injuries in a high-speed motorcycle collision. He required immediate intubation and has remained mechanically ventilated. Three days ago, he developed a temperature of 39.0∘C39.0^\circ\text{C} (102.2∘F102.2^\circ\text{F}), a heart rate of 112/min112/\text{min}, thick purulent airway secretions, and a leukocytosis of 18,500/μL18,500/\mu\text{L}. A portable chest radiograph demonstrated a new dense consolidation in the right lower lobe. He was promptly started on a broad-spectrum empiric antimicrobial regimen consisting of intravenous vancomycin, cefepime, and tobramycin.

Today, his clinical trajectory has improved; his temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), his heart rate is 85/min85/\text{min}, and his fraction of inspired oxygen (FiO2\text{FiO}_2) has been successfully titrated down. Blood cultures drawn three days ago show no growth. A quantitative culture of an endotracheal aspirate obtained at the onset of his fever grew >105 colony-forming units/mL>10^5\text{ colony-forming units/mL} of *Pseudomonas aeruginosa*. The isolate's susceptibility profile is as follows:

Amikacin: Susceptible
Cefepime: Susceptible
Ciprofloxacin: Susceptible
Meropenem: Susceptible
Tobramycin: Susceptible

Routine morning laboratory results reveal a serum creatinine level of 2.2 mg/dL2.2 \text{ mg/dL}, which has climbed from a baseline of 1.0 mg/dL1.0 \text{ mg/dL} on admission.

Which of the following is the most appropriate next step in the management of this patient's infection?

Show answer & explanation

Answer: Discontinue vancomycin and tobramycin, and continue cefepime.

Answer

Discontinue vancomycin and tobramycin, and continue cefepime.
The patient developed ventilator-associated pneumonia (VAP) and was initially given appropriate empiric therapy. Once culture data identifies a specific pathogen and its susceptibilities, antimicrobial stewardship principles dictate de-escalating to targeted, narrower-spectrum therapy. Since the cultures grew only *Pseudomonas aeruginosa*, MRSA coverage (vancomycin) is no longer indicated. Furthermore, for a patient with *P. aeruginosa* VAP who is clinically stabilizing, definitive treatment with a single active beta-lactam agent (in this case, cefepime) is recommended over combination therapy. Continuing the aminoglycoside (tobramycin) provides no additional clinical benefit and actively exacerbates the patient's ongoing acute kidney injury. Therefore, the best step is to stop vancomycin and tobramycin and complete the course with cefepime monotherapy.

Step-by-Step Solution

1
Analyze the patient's initial presentation and the rationale for empiric therapy.
The patient developed ventilator-associated pneumonia (VAP) and was appropriately started on broad-spectrum therapy (vancomycin, cefepime, tobramycin) to cover multidrug-resistant pathogens including MRSA and Pseudomonas.
Empiric therapy for severe healthcare-associated infections must account for local resistance patterns and potentially highly resistant organisms until cultures return.
2
Evaluate the definitive culture and susceptibility data against the patient's clinical status.
Cultures confirmed Pseudomonas aeruginosa sensitive to cefepime, with no MRSA isolated. The patient's clinical status is improving (afebrile, lower oxygen requirements).
Once the responsible pathogen and its susceptibility profile are identified, therapy should be tailored to target that specific organism.
3
Assess for adverse effects of the current medical regimen.
The patient's serum creatinine has more than doubled (1.0 to 2.2 mg/dL), indicating acute kidney injury (AKI).
Both vancomycin and tobramycin are nephrotoxic. Identifying AKI mandates urgent removal of offending agents if they are no longer clinically necessary.
4
Determine the optimal definitive antimicrobial regimen.
Discontinue both vancomycin (no MRSA) and tobramycin (nephrotoxic and unnecessary for double coverage), and continue cefepime monotherapy.
Current guidelines recommend monotherapy with a susceptible beta-lactam for stable patients with Pseudomonas VAP to promote antibiotic stewardship and limit toxicity.

Key Concept

Antimicrobial stewardship in ventilator-associated pneumonia requires de-escalating empiric broad-spectrum regimens to targeted monotherapy once susceptibilities are known and the patient is clinically stable, especially when avoiding drug toxicities like aminoglycoside-induced acute kidney injury.
Question 1545Question →

Match each clinical scenario with its most likely primary acid-base disorder.

Click a left item, then click its matching right item

Items

Severe diarrhea
Opiate overdose
Protracted vomiting
Salicylate toxicity (early phase)

Matches

Show answer & explanation

Answer

Severe diarrhea causes normal anion gap metabolic acidosis; opiate overdose causes respiratory acidosis; protracted vomiting causes metabolic alkalosis; early salicylate toxicity causes respiratory alkalosis.
Each clinical condition triggers a specific primary acid-base disturbance: bicarbonate loss in diarrhea (normal gap acidosis), CO2 retention in opiate overdose (respiratory acidosis), H+ loss in vomiting (metabolic alkalosis), and hyperventilation in early salicylate overdose (respiratory alkalosis).

Step-by-Step Solution

1
Identify the primary disturbance in severe diarrhea
Normal anion gap metabolic acidosis
Gastrointestinal loss of bicarbonate leads to a non-anion gap (hyperchloremic) metabolic acidosis.
2
Identify the primary disturbance in opiate overdose
Respiratory acidosis
Central respiratory depression leads to hypoventilation and retention of carbon dioxide.
3
Identify the primary disturbance in protracted vomiting
Metabolic alkalosis
Loss of gastric hydrochloric acid and volume contraction leads to metabolic alkalosis.
4
Identify the primary disturbance in early salicylate toxicity
Respiratory alkalosis
Salicylates directly stimulate the medullary respiratory center, causing hyperventilation and blowing off carbon dioxide.

Key Concept

Primary Acid-Base Disorders and Their Etiologies
Question 1546Question →

Match each commonly prescribed medication with its primary mechanism of inducing acute kidney injury (AKI).

Click a left item, then click its matching right item

Items

Gentamicin
Ibuprofen
Nafcillin
Intravenous Acyclovir

Matches

Show answer & explanation

Answer

Gentamicin causes direct tubular toxicity (ATN). Ibuprofen causes hemodynamically mediated AKI via afferent vasoconstriction. Nafcillin induces an allergic acute interstitial nephritis (AIN). Intravenous acyclovir causes intratubular obstruction via crystal precipitation.
Each medication listed corresponds to a distinct pathophysiological mechanism of acute kidney injury. Aminoglycosides (gentamicin) directly damage the proximal tubule resulting in ATN. NSAIDs (ibuprofen) block the synthesis of vasodilatory prostaglandins, leading to afferent arteriolar vasoconstriction and decreased GFR (prerenal/hemodynamic AKI). Beta-lactams (nafcillin) act as haptens to trigger an allergic, cell-mediated immune response in the renal interstitium (AIN). Acyclovir, particularly when administered intravenously without adequate hydration, crystallizes within the tubular lumen, causing crystal-induced intrarenal obstruction.

Step-by-Step Solution

1
Identify the mechanism of aminoglycoside-induced nephrotoxicity.
Gentamicin causes direct toxic injury to proximal tubular epithelial cells (Acute Tubular Necrosis).
Aminoglycosides accumulate in the proximal tubule cells, leading to cellular necrosis and sloughing into the tubular lumen (muddy brown casts).
2
Identify the mechanism of NSAID-induced nephrotoxicity.
Ibuprofen causes inhibition of vasodilatory prostaglandins leading to afferent arteriolar vasoconstriction.
Prostaglandins normally dilate the afferent arteriole to maintain glomerular filtration rate (GFR). NSAIDs block this, reducing renal blood flow.
3
Identify the mechanism of penicillin-induced nephrotoxicity.
Nafcillin causes an idiosyncratic delayed hypersensitivity reaction in the renal interstitium (Acute Interstitial Nephritis).
Beta-lactam antibiotics are a classic trigger for AIN, characterized by interstitial inflammation often with eosinophiluria.
4
Identify the mechanism of acyclovir-induced nephrotoxicity.
Intravenous acyclovir causes precipitation of insoluble metabolites causing intratubular obstruction.
Acyclovir is poorly soluble in urine and can rapidly form crystals in the tubules, especially in volume-depleted patients, causing intrarenal obstruction.

Key Concept

Mechanisms of drug-induced acute kidney injury (AKI)
Question 1547Question →

Match each patient's clinical presentation with the most accurate underlying pathophysiologic description.

Click a left item, then click its matching right item

Items

A 68-year-old man with a history of severe chronic obstructive pulmonary disease is evaluated in the acute care clinic for worsening somnolence and a productive cough. Arterial blood gas on room air shows a pH of 7.247.24, pCO 2_2 of 7272 mm Hg, and calculated HCO 3−_3^- of 3030 mEq/L.
A 55-year-old man with progressive fatigue and deep, rapid breathing (Kussmaul respirations) has laboratory testing showing Na +^+ 140140 mEq/L, Cl −^- 104104 mEq/L, and HCO 3−_3^- 1212 mEq/L, alongside markedly elevated blood urea nitrogen and creatinine levels.
A 72-year-old woman who recently completed a 10-day course of oral levofloxacin for a respiratory tract infection now presents with profuse, foul-smelling, watery diarrhea. Her laboratory results show a leukocyte count of 22,000/mm322,000 / \text{mm}^3.
A 32-year-old woman recently started on oral methimazole for hyperthyroidism reports to the clinic with a sudden onset of rigors and severe odynophagia. A complete blood count reveals an absolute neutrophil count of 200/mm3200 / \text{mm}^3.

Matches

Show answer & explanation

Answer

The clinical vignettes correctly match to: COPD exacerbation with acute-on-chronic respiratory acidosis, uremic high anion gap metabolic acidosis, antibiotic-associated Clostridioides difficile colitis, and methimazole-induced agranulocytosis.
Each matching pair requires identifying the primary diagnosis from the vignette and mapping it to its formal pathophysiologic description. The first patient has alveolar hypoventilation (COPD exacerbation). The second has uremic acidosis (high anion gap). The third has C. difficile colitis (microbial dysbiosis). The fourth has methimazole-induced agranulocytosis (immune-mediated myelopoiesis arrest).

Step-by-Step Solution

1
Evaluate the arterial blood gas for the first patient to determine the primary disturbance.
Identified primary respiratory acidosis with partial metabolic compensation.
Allows accurate classification of the acid-base derangement caused by the acute COPD exacerbation.
2
Calculate the anion gap using the formula: Na +^+ - (Cl −^- + HCO 3−_3^-) for the second patient.
The calculated anion gap is 2424 mEq/L, confirming a high anion gap metabolic acidosis.
Differentiates between normal and high anion gap metabolic acidosis in a patient with renal failure.
3
Assess the temporal relationship between levofloxacin use and the onset of profound leukocytosis and diarrhea in the third patient.
Identifies a high clinical suspicion for Clostridioides difficile colitis.
Broad-spectrum antibiotics disrupt normal flora, leading to opportunistic toxigenic infections.
4
Correlate the initiation of methimazole with the profound neutropenia (ANC 200/mm3200 / \text{mm}^3) in the fourth patient.
Identifies drug-induced agranulocytosis.
Prompt recognition of this idiosyncratic drug toxicity is critical to stop the offending agent and prevent fatal sepsis.

Key Concept

Integration of diverse clinical presentations in general internal medicine, requiring multi-step diagnosis of acid-base disturbances, nosocomial infections, and severe adverse drug reactions based on physical findings and laboratory data.
Question 1548Question →

A 61-year-old man comes to the emergency department due to severe right knee pain and swelling that began abruptly overnight. He reports that the pain is excruciating, and he is unable to bear weight on the right leg. His medical history includes type 2 diabetes mellitus, chronic kidney disease (stage 3a), and a recent hospitalization two weeks ago for a chronic obstructive pulmonary disease exacerbation. His temperature is 38.2°C (100.8°F), blood pressure is 142/88 mm Hg, and pulse is 98/min. Physical examination reveals a markedly swollen, erythematous, and warm right knee. Range of motion is severely limited by pain. There are no skin breaks or ulcerations around the joint. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Perform arthrocentesis of the right knee

Answer

Perform arthrocentesis of the right knee
The correct answer is to perform arthrocentesis because distinguishing between a severe crystal-induced arthropathy and septic arthritis relies entirely on synovial fluid analysis. Given the risk of rapid, irreversible joint destruction with septic arthritis, obtaining fluid for a leukocyte count, Gram stain, culture, and crystal analysis is the most critical initial step.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has an acute monoarticular arthritis with severe inflammatory signs (warmth, erythema, exquisite pain) and a systemic fever.
Identifying the acuity and inflammatory nature of the joint presentation dictates the urgency of the workup.
2
Determine the differential diagnosis.
The presentation is highly suspicious for septic arthritis. However, crystal arthropathies such as gout or pseudogout can also present with fever and identical severe joint findings.
Both infectious and microcrystalline etiologies are medical urgencies that require definitive differentiation.
3
Identify the mandatory next diagnostic step.
Synovial fluid analysis via arthrocentesis is required to evaluate leukocyte count, perform a Gram stain and culture, and assess for crystals.
It is the only method to definitively rule in or rule out a joint infection prior to initiating targeted therapies.

Key Concept

The initial evaluation of acute monoarticular arthritis, particularly when accompanied by fever, requires prompt arthrocentesis and synovial fluid analysis to definitively rule out septic arthritis before initiating condition-specific therapies.
Question 1549Question →

A 65-year-old man is evaluated during a routine follow-up appointment. He reports feeling unusually tired over the past few months, along with new-onset constipation and dry skin. His medical history is notable for the transsphenoidal resection of a nonfunctioning pituitary macroadenoma two years ago. He currently takes no medications. Vital signs are normal except for a heart rate of 58/min. Physical examination reveals delayed relaxation of the deep tendon reflexes. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 1.8 \muU/mL1.8 \text{ \mu U/mL} (normal: 0.5-5.0 \muU/mL0.5\text{-}5.0 \text{ \mu U/mL}) and a free T4 level of 0.5 ng/dL0.5 \text{ ng/dL} (normal: 0.9-1.7 ng/dL0.9\text{-}1.7 \text{ ng/dL}). Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Central hypothyroidism

Answer

Central hypothyroidism
The correct diagnosis is central (secondary) hypothyroidism. The patient has clear clinical features of hypothyroidism, supported by a distinctly low free T4 level. In a normal hypothalamic-pituitary-thyroid axis, a low free T4 removes negative feedback and triggers a compensatory, significant increase in TSH (which would indicate primary hypothyroidism). In this patient, the TSH is inappropriately normal, indicating a failure of the pituitary gland to respond to the low circulating thyroxine levels. This laboratory pattern, combined with his surgical history of a transsphenoidal pituitary macroadenoma resection, firmly establishes the diagnosis of central hypothyroidism.

Step-by-Step Solution

1
Identify the patient's clinical syndrome.
The patient has signs and symptoms of hypothyroidism, including fatigue, constipation, dry skin, bradycardia, and delayed deep tendon reflexes.
Recognizing the clinical presentation guides the interpretation of the subsequent laboratory values.
2
Analyze the thyroid laboratory results.
The free T4 level is low (0.5 ng/dL0.5 \text{ ng/dL}), confirming a hypothyroid state. The TSH level is normal (1.8 \muU/mL1.8 \text{ \mu U/mL}).
Evaluating the relationship between TSH and free T4 is essential for determining the etiology of the thyroid dysfunction.
3
Determine the etiology based on the laboratory pattern and patient history.
A low free T4 should physiologically trigger an elevated TSH. An inappropriately normal TSH indicates pituitary failure, which aligns with his history of pituitary adenoma resection.
Integrating lab patterns with surgical history confirms the specific diagnosis of central (secondary) hypothyroidism.

Key Concept

Diagnosis of Central Hypothyroidism
Estimated Time:45s
Question 1550Question →

A 6262-year-old man with a history of osteoarthritis and type 22 diabetes mellitus presents to the emergency department with acute onset of severe right knee pain, swelling, and a fever of 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}). He is unable to bear weight on the right leg. Physical examination reveals a warm, erythematous, and markedly swollen right knee with a severely restricted range of motion due to pain. Arrange the following steps in the most appropriate chronological sequence for the management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: diagnostic arthrocentesis, followed by empiric intravenous antibiotics, then surgical joint drainage, and finally de-escalation to targeted antimicrobial therapy.
The correct sequence prioritizes obtaining uncontaminated microbiological data, followed immediately by broad-spectrum empiric treatment, then definitive source control, and finally antibiotic stewardship. Arthrocentesis must be performed first to avoid sterilizing the synovial fluid. Empiric antibiotics are given immediately after the tap to halt systemic spread. Surgical drainage is then required because antibiotics cannot fully penetrate the purulent exudate. Finally, once cultures result, therapy is narrowed to target the specific pathogen.

Step-by-Step Solution

1
Diagnose suspected septic arthritis based on the clinical presentation.
The patient's acute fever, severely painful, swollen, and erythematous knee with restricted motion is highly suspicious for septic arthritis.
Prompt recognition is required as this is a joint-threatening and potentially life-threatening orthopedic emergency.
2
Determine the critical first diagnostic intervention.
Diagnostic arthrocentesis must be performed.
Obtaining synovial fluid for cell count, Gram stain, and culture before giving antibiotics is essential to ensure accurate pathogen identification.
3
Select the immediate medical therapy.
Administer empiric broad-spectrum intravenous antibiotics.
Once fluid is obtained, antibiotics targeting MRSA and Gram-negative organisms should be started immediately without waiting for culture results.
4
Identify the necessary definitive source control measure.
Consult orthopedics for surgical joint drainage (irrigation and debridement).
Antibiotics alone are inadequate for purulent closed-space infections; mechanical washout is required to clear the bacterial load.
5
Plan the long-term antimicrobial management.
De-escalate to narrow-spectrum targeted antibiotics.
Once the specific pathogen and its sensitivities are identified, therapy should be tailored to practice good antibiotic stewardship.

Key Concept

Management of acute septic arthritis requires prompt synovial fluid aspiration prior to the initiation of empiric antibiotics, followed by surgical drainage for source control, and eventual de-escalation of antimicrobial therapy based on specific culture results.
Estimated Time:1m 30s
Question 1551Question →

A 25-year-old man presents to the clinic for a routine health maintenance examination. He has no past medical history and takes no medications. The patient reports having unprotected receptive anal intercourse with a new male partner 4 weeks ago. He is currently asymptomatic. Physical examination reveals normal vital signs and no lymphadenopathy, rash, or mucosal lesions. The patient requests screening for sexually transmitted infections, including HIV.

Arrange the following steps in the most appropriate chronological order for the diagnosis and initial management of this patient's suspected HIV infection, in accordance with current guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Initial screening with the 4th-generation HIV-1/2 antigen/antibody combination immunoassay, 2) Confirmation with the HIV-1/HIV-2 antibody differentiation immunoassay, 3) Obtaining baseline blood samples for CD4, viral load, and genotypic resistance testing, and 4) Initiating empiric combination antiretroviral therapy (cART).
The correct sequence follows the current CDC guidelines for HIV diagnosis and the principles of rapid antiretroviral therapy initiation. The diagnostic algorithm always begins with a highly sensitive fourth-generation HIV-1/2 antigen/antibody combination immunoassay. A reactive result must be confirmed with an HIV-1/HIV-2 antibody differentiation immunoassay, which establishes the diagnosis and distinguishes the viral type. Once HIV is confirmed, the standard of care is to initiate combination antiretroviral therapy (cART) as rapidly as possible, often on the same day. However, it is absolutely critical to obtain blood samples for baseline HIV RNA viral load, CD4 cell count, and genotypic resistance testing prior to administering the first dose of cART. If cART is administered before these labs are drawn, the resulting viral suppression can make it impossible to amplify the virus for resistance testing. Conversely, clinicians should not delay cART initiation while awaiting the results of the resistance testing; an empiric regimen is started immediately and adjusted later if necessary.

Step-by-Step Solution

1
Identify the recommended initial screening test for HIV.
The fourth-generation HIV-1/2 antigen/antibody combination immunoassay is the standard initial step.
This test detects both the p24 viral antigen (present during acute infection) and HIV antibodies, offering the highest sensitivity for early detection.
2
Determine the appropriate confirmatory test following a reactive screening assay.
The HIV-1/HIV-2 antibody differentiation immunoassay is performed.
Current guidelines require this assay to confirm the diagnosis and differentiate between HIV-1 and HIV-2, which is essential because HIV-2 has intrinsic resistance to certain antiretrovirals (e.g., NNRTIs). The Western blot is obsolete.
3
Establish the sequence of baseline laboratory testing versus treatment initiation.
Blood samples for CD4 count, viral load, and genotypic resistance testing must be obtained before initiating therapy.
Starting antiretroviral therapy will rapidly suppress viral replication. If therapy is started before blood is drawn, the viral load may become too low to perform genotypic resistance testing, depriving the clinician of vital baseline information.
4
Determine the timing for initiating antiretroviral therapy.
Empiric combination antiretroviral therapy (cART) is initiated immediately after baseline labs are drawn.
The 'rapid start' strategy (same-day initiation) improves immunologic outcomes and decreases the risk of transmission. Clinicians should not wait for the resistance testing results to return before starting cART.

Key Concept

The CDC HIV diagnostic algorithm and the principles of rapid antiretroviral therapy initiation.
Estimated Time:1m 30s
Question 1552Question →

A 6868-year-old woman is evaluated in the hospital on postoperative day 77 following an elective right total hip arthroplasty. Since the surgery, she has been receiving subcutaneous enoxaparin for deep venous thrombosis prophylaxis. She now reports new-onset right leg pain and swelling that began this morning. Temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 132/82 mm Hg132/82\text{ mm Hg}, pulse is 92/min92/\text{min}, and respirations are 16/min16/\text{min}. Physical examination shows a swollen, erythematous right lower extremity with tenderness to palpation over the calf and thigh.

Laboratory studies:
Hemoglobin: 11.2 g/dL11.2\text{ g/dL}
Leukocyte count: 7,800/mm37,800/\text{mm}^3
Platelet count: 52,000/mm352,000/\text{mm}^3 (Preoperative platelet count was 260,000/mm3260,000/\text{mm}^3)

A lower extremity venous duplex ultrasound reveals a noncompressible segment in the right femoral vein consistent with an acute deep venous thrombosis. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue enoxaparin and initiate argatroban

Answer

Discontinue enoxaparin and initiate argatroban
This patient's presentation of a new deep venous thrombosis (DVT) accompanied by a sudden, significant drop in platelets (>50%>50\%) occurring 77 days after starting enoxaparin is highly suspicious for Heparin-Induced Thrombocytopenia (HIT) Type 2. HIT is a prothrombotic, autoimmune disorder caused by antibodies against the heparin-platelet factor 4 (PF4) complex. The most appropriate next step in management for a patient with a high pretest probability of HIT is the immediate discontinuation of all heparin products (including low-molecular-weight heparins like enoxaparin) and the initiation of a non-heparin anticoagulant, such as the direct thrombin inhibitor argatroban or bivalirudin.

Step-by-Step Solution

1
Evaluate the timing and severity of thrombocytopenia in conjunction with the new thrombosis.
The patient meets criteria for a high probability of Heparin-Induced Thrombocytopenia (HIT) based on the 4T score: a >50%>50\% platelet drop, symptom onset between days 55-1010 of therapy, and a new acute thrombosis.
A high pretest probability mandates immediate changes to clinical management before awaiting confirmatory laboratory testing.
2
Discontinue the offending pharmacological agent.
Subcutaneous enoxaparin (a low-molecular-weight heparin) must be stopped immediately.
Continuing any heparin product will propagate the immune-mediated platelet activation and worsen the condition.
3
Initiate alternative systemic anticoagulation.
A non-heparin anticoagulant, such as the direct thrombin inhibitor argatroban, is initiated.
Patients with HIT are highly prothrombotic and require immediate alternative anticoagulation to prevent or treat life-threatening clots.

Key Concept

Patients with suspected Heparin-Induced Thrombocytopenia (HIT) must have all heparin products immediately discontinued and be started on a non-heparin anticoagulant, such as argatroban.

Alternative Method

The 4T score (Thrombocytopenia, Timing, Thrombosis, and oTher causes) can be quickly calculated to establish pretest probability. A score of 6-8 indicates high probability, warranting immediate action before laboratory confirmation via serotonin release assay or PF4 ELISA.
Estimated Time:1m 15s
Question 1553Question →

Paramedics arrive at the emergency room with a 52-year-old man who was discovered unresponsive in a public park. The patient has a documented medical history of severe alcohol use disorder. Upon initial evaluation, his body temperature is 36.2∘C36.2^\circ\text{C} (97.2∘F97.2^\circ\text{F}), pulse is 102/min102/\text{min}, blood pressure is 110/70 mm Hg110/70\text{ mm Hg}, and respirations are 24/min24/\text{min}. He is unarousable to painful stimuli. Cardiopulmonary examination is unremarkable. Initial laboratory studies show the following:

Laboratory ParameterValue
Serum sodium137 mEq/L137\text{ mEq/L}
Serum potassium4.5 mEq/L4.5\text{ mEq/L}
Serum chloride98 mEq/L98\text{ mEq/L}
Serum bicarbonate12 mEq/L12\text{ mEq/L}
Blood urea nitrogen56 mg/dL56\text{ mg/dL}
Serum creatinine1.8 mg/dL1.8\text{ mg/dL}
Serum glucose162 mg/dL162\text{ mg/dL}
Serum ethanol138 mg/dL138\text{ mg/dL}
Measured serum osmolality368 mOsm/kg H2O368\text{ mOsm/kg H}_2\text{O}

Arterial blood gas (room air) shows a pH of 7.227.22 and a PaCO2\text{PaCO}_2 of 26 mm Hg26\text{ mm Hg}.

Based on the provided laboratory results, what is the patient's serum osmolar gap in mOsm/kg\text{mOsm/kg}?

Show answer & explanation

Answer: 35

Answer

35
The correct osmolar gap is 35. The patient presents with an elevated anion gap metabolic acidosis (Anion Gap = 137 - 98 - 12 = 27). In such cases, evaluating the osmolar gap is crucial to identifying toxic alcohol ingestion. The calculated serum osmolality must account for sodium, glucose, blood urea nitrogen (BUN), and any measured ethanol. The full formula is: 2×[Na+]+[Glucose]18+[BUN]2.8+[Ethanol]4.62 \times [\text{Na}^+] + \frac{[\text{Glucose}]}{18} + \frac{[\text{BUN}]}{2.8} + \frac{[\text{Ethanol}]}{4.6}. Plugging in the values gives 2(137)+16218+562.8+1384.6=274+9+20+30=333 mOsm/kg2(137) + \frac{162}{18} + \frac{56}{2.8} + \frac{138}{4.6} = 274 + 9 + 20 + 30 = 333\text{ mOsm/kg}. The osmolar gap is the measured osmolality minus the calculated osmolality (368−333=35368 - 333 = 35). An osmolar gap greater than 10 to 15 mOsm/kg suggests the presence of unmeasured osmotically active substances, such as methanol or ethylene glycol, which require urgent intervention.

Step-by-Step Solution

1
Recall the formula for calculated serum osmolality.
Calculated Osmolality = 2×[Na+]+[Glucose]18+[BUN]2.8+[Ethanol]4.62 \times [\text{Na}^+] + \frac{[\text{Glucose}]}{18} + \frac{[\text{BUN}]}{2.8} + \frac{[\text{Ethanol}]}{4.6}
To determine the osmolar gap, the expected (calculated) osmolality must first be determined, accounting for all major osmotically active substances including ethanol.
2
Input the patient's laboratory values into the formula.
Calculated Osm = 2(137)+16218+562.8+1384.62(137) + \frac{162}{18} + \frac{56}{2.8} + \frac{138}{4.6}
Standard conversion factors are used to convert mg/dL to mmol/L (mOsm/kg).
3
Compute the sum of the components.
274+9+20+30=333 mOsm/kg H2O274 + 9 + 20 + 30 = 333\text{ mOsm/kg H}_2\text{O}
This represents the osmolality expected from the known solutes in the patient's blood.
4
Calculate the osmolar gap.
Osmolar gap = Measured Osmolality - Calculated Osmolality = 368−333=35 mOsm/kg H2O368 - 333 = 35\text{ mOsm/kg H}_2\text{O}
The difference reveals the presence of unmeasured osmotically active substances (e.g., toxic alcohols like methanol or ethylene glycol).

Key Concept

The serum osmolar gap is calculated by subtracting the calculated osmolality from the measured osmolality. When ethanol is present, it must be included in the calculated osmolality formula to accurately assess for the presence of other toxic alcohols.
Estimated Time:1m 30s
Question 1554Question →

Match each patient's clinical and histopathologic presentation with the corresponding defining cytogenetic abnormality and characteristic therapeutic approach.

Click a left item, then click its matching right item

Items

A 52-year-old woman presents with early satiety and left upper quadrant fullness. Complete blood count shows a leukocyte count of 75,000/mm3 with absolute basophilia and an elevated lactate dehydrogenase.
A 38-year-old man presents with epistaxis, widespread ecchymoses, and gingival bleeding. Coagulation studies reveal elevated D-dimer, prolonged prothrombin time, and decreased fibrinogen. Smear shows abnormal cells with numerous cytoplasmic needle-like inclusions.
A 10-year-old boy of East African descent is evaluated for a rapidly expanding, non-tender jaw mass. Histology of the mass reveals a high mitotic index with scattered macrophages containing apoptotic debris.
A 62-year-old woman is evaluated for waxing and waning painless cervical and axillary lymphadenopathy. Excisional biopsy demonstrates a nodular proliferation of small cleaved cells lacking macrophages.

Matches

Show answer & explanation

Answer

Patient 1 (CML) matches with the t(9;22) translocation. Patient 2 (APL) matches with the t(15;17) translocation. Patient 3 (Burkitt Lymphoma) matches with the t(8;14) translocation. Patient 4 (Follicular Lymphoma) matches with the t(14;18) translocation.
Each hematologic malignancy has a defining genetic lesion that dictates its clinical behavior and treatment. CML is driven by the BCR-ABL1 fusion from t(9;22) and is treated with tyrosine kinase inhibitors. APL is driven by the PML-RARA fusion from t(15;17), causing a differentiation block that is reversed by ATRA. Burkitt lymphoma relies on c-MYC overexpression from t(8;14), causing rapid proliferation requiring aggressive chemotherapy. Follicular lymphoma is driven by BCL2 overexpression from t(14;18), preventing apoptosis and presenting as an indolent disease often managed with anti-CD20 therapy.

Step-by-Step Solution

1
Diagnose the specific hematologic malignancy based on the clinical vignette.
Patient 1 has Chronic Myeloid Leukemia. Patient 2 has Acute Promyelocytic Leukemia. Patient 3 has Burkitt Lymphoma. Patient 4 has Follicular Lymphoma.
Synthesizing the presenting symptoms, laboratory abnormalities (e.g., basophilia, DIC panel), and classic histologic descriptions allows for accurate primary diagnosis.
2
Connect the diagnosed malignancy with its defining molecular pathophysiology and treatment strategy.
CML correlates with t(9;22) and tyrosine kinase inhibitors. APL correlates with t(15;17) and all-trans retinoic acid. Burkitt Lymphoma correlates with t(8;14) and intensive chemotherapy. Follicular Lymphoma correlates with t(14;18) and rituximab.
Understanding the specific cytogenetic drivers of leukemias and lymphomas is necessary to determine their corresponding targeted therapeutic interventions.

Key Concept

Molecular cytogenetics and associated targeted therapies in hematologic malignancies.
Estimated Time:1m 30s
Question 1555Question →

A 41-year-old woman is evaluated in the clinic for progressive fatigue, cold intolerance, and a 6-kg (13-lb) weight gain over the past eight months. She has also experienced diffuse muscle aches and secondary amenorrhea during this time. A urine pregnancy test is negative. She takes no medications and has no significant past medical history. Vital signs show a blood pressure of 102/64102/64 mmHg and a pulse of 5454/min. Physical examination reveals dry skin, a pale appearance, and delayed relaxation of the Achilles tendon reflexes. Palpation of the anterior neck reveals no thyromegaly or nodules.

Laboratory results are as follows:

ParameterResultReference Range
Sodium133133 mEq/L136−145136 - 145 mEq/L
Potassium4.24.2 mEq/L3.5−5.03.5 - 5.0 mEq/L
Thyroid-stimulating hormone (TSH)1.41.4 μ\muU/mL0.5−5.00.5 - 5.0 μ\muU/mL
Free thyroxine (T4)0.50.5 ng/dL0.9−1.70.9 - 1.7 ng/dL

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Measurement of early morning serum cortisol

Answer

Measurement of early morning serum cortisol
The correct action is to measure an early morning serum cortisol level. This patient's laboratory values (low free T4, normal TSH) indicate central hypothyroidism. Because central hypothyroidism often coexists with other pituitary hormone deficiencies (panhypopituitarism), secondary adrenal insufficiency must be ruled out. Starting levothyroxine increases cortisol clearance; if cortisol is already low and cannot be appropriately upregulated by the damaged pituitary, the patient will be thrust into a fatal adrenal crisis. Therefore, assessing the adrenal axis takes immediate precedence before thyroid replacement.

Step-by-Step Solution

1
Interpret the thyroid function tests to determine the primary site of pathology.
The patient has a frankly low free T4 combined with a TSH level that is within the normal reference range. This confirms central (secondary) hypothyroidism.
In primary hypothyroidism, the pituitary responds to a low T4 by drastically increasing TSH production. An inappropriately normal or low TSH in the setting of low T4 indicates that the pituitary gland or hypothalamus is failing.
2
Correlate the central endocrine defect with the clinical presentation.
The patient's central hypothyroidism, coupled with secondary amenorrhea and mild hyponatremia, suggests panhypopituitarism (deficiency of multiple anterior pituitary hormones including TSH, FSH/LH, and potentially ACTH).
Pituitary pathology (such as a non-functioning macroadenoma) rarely affects only a single hormone axis. The mild hyponatremia and low-normal blood pressure raise a high suspicion for concurrent secondary adrenal insufficiency due to ACTH deficiency.
3
Determine the safest sequential step for therapeutic management.
The adrenal axis must be evaluated by measuring an early morning serum cortisol level before any thyroid replacement is administered.
Initiating levothyroxine accelerates the body's metabolic rate and enhances the metabolism and clearance of cortisol. If a patient with central hypothyroidism has undiagnosed adrenal insufficiency, starting thyroid hormone without concurrent glucocorticoid replacement can rapidly precipitate a life-threatening adrenal crisis.

Key Concept

In patients diagnosed with central hypothyroidism (low T4 with inappropriately normal/low TSH), the hypothalamic-pituitary-adrenal axis must be evaluated (via early morning serum cortisol) before initiating levothyroxine therapy to prevent precipitating an acute adrenal crisis.
Question 1556Question →

An electrocardiogram previously documented ventricular tachycardia in a 6868-year-old man. He now visits the physician complaining of severe palpitations, unintended weight loss, and profound fatigue persisting for the last 33 weeks. His medical history includes ischemic cardiomyopathy and placement on a rhythm-control medication approximately 1414 months ago. Current medications include lisinopril, carvedilol, and aspirin. The patient's temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 142/86142/86 mm Hg, and pulse is 115115/min and irregularly irregular. Physical examination demonstrates brisk deep tendon reflexes and a prominent bilateral hand tremor. Palpation of the neck reveals a diffusely firm, slightly enlarged thyroid gland with no distinct nodules.

Laboratory studies reveal:
Thyroid-stimulating hormone (TSH): <0.01 μU/mL<0.01 \ \mu\text{U/mL}
Free thyroxine (T4): 4.1 ng/dL4.1 \text{ ng/dL}
Total triiodothyronine (T3): 195 ng/dL195 \text{ ng/dL}

A 2424-hour radioactive iodine uptake scan demonstrates 1%1\% uptake. Subsequent color Doppler ultrasonography of the thyroid shows a diffusely enlarged gland with markedly diminished internal vascularity. Which of the following is the most appropriate next step in the management of this patient's current condition?

Show answer & explanation

Answer: Initiation of oral prednisone

Answer

Initiation of oral prednisone
The correct answer is the initiation of oral prednisone. This patient has amiodarone-induced thyrotoxicosis (AIT). Amiodarone is an iodine-rich antiarrhythmic drug that can cause thyrotoxicosis via two distinct mechanisms. Type 1 AIT typically occurs in patients with underlying thyroid pathology (e.g., multinodular goiter) and involves iodine-induced overproduction of thyroid hormone; Doppler ultrasonography shows increased vascularity, and the treatment of choice is thionamides (e.g., methimazole). In contrast, Type 2 AIT is a destructive thyroiditis where preformed thyroid hormone is released into the circulation, typically occurring in normal thyroid glands. Color Doppler ultrasonography demonstrates markedly decreased vascularity, as seen in this patient. Because the mechanism is inflammatory destruction rather than hormone synthesis, thionamides are ineffective. The first-line treatment for Type 2 AIT is glucocorticoids (e.g., prednisone). The 24-hour radioactive iodine uptake is uniformly low in both types due to competitive inhibition by the massive iodine load from amiodarone, making it unhelpful for distinguishing between the two.

Step-by-Step Solution

1
Identify the underlying cause of the patient's thyrotoxicosis based on the medical history.
The patient has a history of ventricular tachycardia treated with an unnamed rhythm-control drug, which is amiodarone. Amiodarone is known to cause thyroid dysfunction.
Amiodarone contains a massive iodine load and exerts direct toxic effects on thyroid follicular cells.
2
Differentiate between the subtypes of amiodarone-induced thyrotoxicosis using the provided diagnostic tests.
The color Doppler ultrasound shows markedly diminished internal vascularity, pointing definitively to a destructive thyroiditis (Type 2 AIT) rather than increased hormone synthesis (Type 1 AIT).
Radioactive iodine uptake is uniformly low (e.g., 1%) in both AIT types due to the intense iodine load from the drug, making color Doppler ultrasound the essential differentiating test.
3
Determine the appropriate pharmacotherapy for the identified subtype.
Glucocorticoids, such as oral prednisone, are selected to treat the destructive inflammatory process.
Because Type 2 AIT involves the release of preformed hormone via cellular destruction, hormone synthesis inhibitors like methimazole are ineffective.

Key Concept

Management of Type 2 Amiodarone-Induced Thyrotoxicosis (Destructive Thyroiditis)
Question 1557Question →

A 19-year-old college student presents to the student health clinic complaining of severe, watery diarrhea for the past 3 days after returning from a camping trip. He reports feeling profoundly weak and lightheaded when standing. His temperature is 37.2°C (99.0°F), blood pressure is 98/60 mm Hg while supine and 82/50 mm Hg while standing, and pulse is 115/min. Physical examination shows dry mucous membranes and delayed capillary refill. Laboratory results reveal:

Serum sodium: 138 mEq/L138 \text{ mEq/L}
Serum potassium: 3.1 mEq/L3.1 \text{ mEq/L}
Serum chloride: 112 mEq/L112 \text{ mEq/L}
Serum bicarbonate: 14 mEq/L14 \text{ mEq/L}

Arterial blood gas on room air:
pH: 7.28
pCO2pCO_2: 29 mm Hg
pO2pO_2: 95 mm Hg

Based on the laboratory findings, which of the following best characterizes this patient's acid-base status?

Show answer & explanation

Answer: Normal anion gap metabolic acidosis with appropriate respiratory compensation

Answer

Normal anion gap metabolic acidosis with appropriate respiratory compensation
The patient's presentation of severe diarrhea has led to a primary metabolic acidosis, evidenced by a pH of 7.28 and a low serum bicarbonate of 14 mEq/L14 \text{ mEq/L}. The anion gap is calculated as Na+−(Cl−+HCO3−)=138−(112+14)=12 mEq/LNa^+ - (Cl^- + HCO_3^-) = 138 - (112 + 14) = 12 \text{ mEq/L}, which is normal (reference range: 8-12 mEq/L). To determine if the respiratory compensation is appropriate, Winter's formula is applied: Expected pCO2=1.5×[HCO3−]+8±2pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2. For this patient, 1.5×14+8±2=29±2 mm Hg1.5 \times 14 + 8 \pm 2 = 29 \pm 2 \text{ mm Hg}. The patient's actual pCO2pCO_2 is 29 mm Hg, which falls precisely within the expected range, indicating an appropriate respiratory compensation.

Step-by-Step Solution

1
Identify the primary acid-base disorder by evaluating the pH.
The pH is 7.28, indicating acidemia. The low serum bicarbonate (14 mEq/L) confirms a primary metabolic acidosis.
Establishing the primary driver of the pH abnormality is the first step in any acid-base interpretation.
2
Calculate the serum anion gap to classify the metabolic acidosis.
Anion Gap = Na+−(Cl−+HCO3−)=138−(112+14)=12 mEq/LNa^+ - (Cl^- + HCO_3^-) = 138 - (112 + 14) = 12 \text{ mEq/L}. This is a normal anion gap.
Metabolic acidosis must be divided into normal anion gap (hyperchloremic) and high anion gap categories to narrow the differential diagnosis.
3
Calculate the expected respiratory compensation using Winter's formula.
Expected pCO2=1.5×[HCO3−]+8±2=1.5×14+8±2=21+8±2=29±2 mm HgpCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2 = 1.5 \times 14 + 8 \pm 2 = 21 + 8 \pm 2 = 29 \pm 2 \text{ mm Hg}.
Winter's formula determines if the lungs are appropriately blowing off CO2CO_2 to compensate for the metabolic acidosis.
4
Compare the actual pCO2pCO_2 to the expected pCO2pCO_2.
The actual pCO2pCO_2 is 29 mm Hg, which is exactly within the expected range of 27-31 mm Hg.
Because actual matches expected, there is no secondary, concurrent respiratory disorder.

Key Concept

Patients with severe diarrhea lose bicarbonate in the stool, leading to a normal anion gap metabolic acidosis (NAGMA). Appropriate respiratory compensation is verified using Winter's formula: Expected pCO2=1.5×[HCO3−]+8±2pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2.
Question 1558Question →

A 31-year-old woman is evaluated in the outpatient clinic for progressive fatigue, cold intolerance, and generalized weakness over the past 5 months. She also reports a complete cessation of menses since the birth of her son 6 months ago. The patient's pregnancy was complicated by placental abruption, which resulted in significant blood loss requiring emergency cesarean delivery and transfusion of packed red blood cells. She was unable to breastfeed despite multiple attempts. Vital signs show a blood pressure of 90/60 mmHg and a pulse of 58/min. Physical examination reveals pale, dry skin and a delay in the relaxation phase of the deep tendon reflexes.

Laboratory results are as follows:
Sodium: 134 mEq/L
Potassium: 4.1 mEq/L
Thyroid-stimulating hormone (TSH): 2.1 μ\mu U/mL (normal: 0.5-5.0 μ\mu U/mL)
Free thyroxine (T4): 0.3 ng/dL (normal: 0.9-1.7 ng/dL)

Which of the following best describes the underlying pathogenesis of this patient's current condition?

Show answer & explanation

Answer: Ischemic necrosis of the anterior pituitary gland

Answer

The correct answer is ischemic necrosis of the anterior pituitary gland, which causes Sheehan syndrome.
The patient's presentation of agalactia, amenorrhea, fatigue, hypotension, and hyponatremia following a severe postpartum hemorrhage (placental abruption) is classic for Sheehan syndrome. During pregnancy, the anterior pituitary gland enlarges and becomes highly vascular, making it vulnerable to hypoperfusion. A massive obstetrical hemorrhage causes ischemic necrosis of the anterior pituitary, leading to panhypopituitarism. The laboratory findings confirm this: a low free T4 with an inappropriately normal TSH indicates central hypothyroidism, and hyponatremia with normal potassium indicates secondary adrenal insufficiency (since aldosterone production is regulated by the renin-angiotensin-aldosterone system, not ACTH).

Step-by-Step Solution

1
Identify the clinical syndrome from the patient's history and physical examination.
The patient has agalactia, amenorrhea, fatigue, and hypotension following a severe postpartum hemorrhage.
Recognizing the constellation of symptoms following a complicated delivery points toward a systemic endocrine failure rather than an isolated primary gland issue.
2
Interpret the provided laboratory data.
The patient has a low free T4 with an inappropriately normal TSH, indicating central hypothyroidism. She also has hyponatremia with normal potassium, indicating secondary adrenal insufficiency.
Differentiating between primary and secondary endocrine failure is crucial for determining the anatomical site of the pathology.
3
Correlate the clinical history with the laboratory findings to determine the pathogenesis.
The combination of panhypopituitarism following massive obstetrical hemorrhage is characteristic of Sheehan syndrome, which is caused by ischemic necrosis of the pituitary gland.
The anterior pituitary enlarges during pregnancy, making it uniquely susceptible to ischemic necrosis during severe hypotensive episodes.

Key Concept

Sheehan syndrome is characterized by ischemic necrosis of the anterior pituitary gland secondary to severe postpartum hemorrhage, leading to panhypopituitarism (e.g., agalactia, amenorrhea, central hypothyroidism, and secondary adrenal insufficiency).
Estimated Time:1m 30s
Question 1559Question →

A 42-year-old woman is evaluated in the rheumatology clinic for worsening episodes of painful blanching and cyanosis in her fingers upon exposure to cold air. She has a known history of diffuse cutaneous systemic sclerosis and currently takes no medications for her vascular symptoms. Arrange the following therapeutic interventions for secondary Raynaud phenomenon in the correct sequential order of escalation, from initial management to salvage therapy for critical ischemia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct escalation sequence is: lifestyle modifications, followed by oral calcium channel blockers, then addition of phosphodiesterase-5 inhibitors, followed by intravenous prostanoids for severe ischemia, and finally surgical digital sympathectomy as salvage therapy.
The management of secondary Raynaud phenomenon follows a strict step-up approach. It begins with essential lifestyle modifications. When pharmacotherapy is needed, a dihydropyridine calcium channel blocker (e.g., nifedipine) is the first-line choice. If monotherapy fails, a phosphodiesterase-5 inhibitor (e.g., sildenafil) is added. For severe manifestations like digital ulcers or critical ischemia, intravenous prostanoids (e.g., iloprost) are indicated. Surgical digital sympathectomy is strictly a salvage therapy for impending tissue necrosis.

Step-by-Step Solution

1
Establish baseline management
Lifestyle modifications
Conservative measures are universally recommended as the foundational first step for all patients with Raynaud phenomenon.
2
Select first-line pharmacotherapy
Oral dihydropyridine calcium channel blocker
When lifestyle measures are insufficient, oral CCBs are the most effective and widely accepted initial vasodilators.
3
Escalate oral therapy
Add a phosphodiesterase-5 inhibitor
For persistent symptoms despite CCB monotherapy, adding a second oral agent with a different vasodilatory mechanism is required.
4
Manage severe complications
Intravenous prostanoids
The development of critical ischemia or digital ulcers necessitates potent intravenous vasodilatory therapy.
5
Consider salvage therapy
Surgical digital sympathectomy
When all medical options are exhausted and tissue loss is imminent, sympathectomy is the final intervention.

Key Concept

The stepwise escalation of therapy for secondary Raynaud phenomenon in systemic sclerosis progresses from conservative lifestyle measures to oral vasodilators, followed by intravenous therapies, and finally surgical intervention.
Estimated Time:1m 0s
Question 1560Question →

A physician is evaluating four different patients in the outpatient clinic who present with varying signs of adrenal dysfunction. Match each patient's clinical presentation and characteristic laboratory profile to the most likely underlying adrenal disorder.

Click a left item, then click its matching right item

Items

Primary adrenal insufficiency
Secondary adrenal insufficiency
Primary hyperaldosteronism
Cortisol-producing adrenal adenoma

Matches

Show answer & explanation

Answer

Primary adrenal insufficiency matches the hyperpigmented patient with high ACTH and hyperkalemia. Secondary adrenal insufficiency matches the patient with prior steroid use, low ACTH, and normal potassium. Primary hyperaldosteronism matches the hypertensive patient with high aldosterone, low renin, and hypokalemia. Cortisol-producing adenoma matches the centrally obese patient with high cortisol and suppressed ACTH.
Each disorder presents with a specific laboratory profile dictated by physiological feedback loops. Primary gland failure results in decreased peripheral hormone and elevated trophic hormone, whereas autonomous peripheral hormone production suppresses the trophic hormone. The preservation of aldosterone in pituitary disease distinguishes it from primary adrenal failure.

Step-by-Step Solution

1
Analyze the hypothalamic-pituitary-adrenal (HPA) axis feedback loop for each clinical presentation.
Identify that primary disorders feature abnormal hormone levels from the adrenal gland with compensatory changes in trophic hormones, while secondary disorders start with abnormal pituitary ACTH.
This fundamental principle distinguishes primary from secondary endocrine pathologies.
2
Differentiate the two forms of adrenal insufficiency based on potassium levels and hyperpigmentation.
The patient with hyperkalemia and hyperpigmentation has primary disease (loss of aldosterone and high ACTH), whereas the patient with normal potassium has secondary disease (intact renin-angiotensin-aldosterone system).
Aldosterone is primarily regulated by the renin-angiotensin-aldosterone system (RAAS), not ACTH, keeping potassium normal in secondary disease.
3
Identify the specific overproduction syndromes based on the isolated hormone excess.
The patient with hypokalemia, hypertension, and suppressed renin has primary hyperaldosteronism. The patient with central obesity and suppressed ACTH has a cortisol-producing adenoma.
Autonomous hormone production exerts negative feedback on normal regulatory mechanisms (renin and ACTH, respectively).

Key Concept

Endocrine feedback loops and the differentiation of primary versus secondary adrenal disorders based on ACTH and electrolyte levels.
PreviousPage 78 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 78 | Examkin